Other Events ·
On August 14, 2026, Haemonetics Corporation entered into a non-exclusive supply agreement with CSL Plasma Inc.…
HAEHaemonetics Corp
On August 14, 2026, Haemonetics Corporation entered into a non-exclusive supply agreement with CSL Plasma Inc., allowing CSL to utilize the Company’s NexSys PCS devices with Persona PLUS technology and purchase related disposables in the United States. The agreement does not contain minimum purchase commitments, and while Haemonetics anticipates CSL will transition a portion of its U.S. plasma collection centers to these products, the scope and timing remain undetermined. Consequently, the company is not updating its fiscal 2027 guidance but expects to provide an update on financial impact during its second fiscal quarter earnings call in November 2026. Haemonetics Corporation operates in the medical technology industry, designing and manufacturing devices for blood collection, processing, and storage.